Table 1 Comparison of clinicopathological information between MPC and SPC

From: Genomic alterations in oral multiple primary cancers

Items

MPCs

SPC

P

Patients

34

202

Ā 

Gender

Ā Ā Ā 

ā€ƒMale

10 (29.41%)

130 (64.36%)

<0.001

ā€ƒFemale

24 (70.59%)

72 (35.64%)

The mean age at 1st diagnosis (year)

60

58

=0.418

Smoking

Ā Ā Ā 

ā€ƒYes

6 (17.65%)

122 (60.40%)

<0.001

ā€ƒNo

28 (82.35%)

80 (39.60%)

Drinking

Ā Ā Ā 

ā€ƒYes

4 (11.76%)

61 (30.20%)

<0.001

ā€ƒNo

30 (88.24%)

141 (69.80%)

Tumors

71

202

Ā 

Tumor size

Ā Ā Ā 

ā€ƒT1

66 (92.96%)

93 (46.04%)

<0.001

ā€ƒT2 + T3 + T4

5 (7.04%)

109 (53.96%)

Lymph node metastases

Ā Ā Ā 

ā€ƒYes

13 (18.31%)

78 (38.61%)

=0.002

ā€ƒNo

58 (81.69%)

124 (61.39%)

Pathology grade

Ā Ā Ā 

ā€ƒWell

66 (92.96%)

123 (60.89%)

<0.001

ā€ƒPoor

5 (7.04%)

79 (39.11%)

Location

Ā Ā Ā 

ā€ƒGingiva

25 (35.21%)

40 (19.80%)

<0.001

ā€ƒBuccal mucosa

15 (21.13%)

22 (10.89%)

ā€ƒTongue

18 (25.35%)

79 (39.11%)

ā€ƒLip

5 (7.04%)

8 (3.96%)

ā€ƒPalate

5 (7.04%)

7 (3.47%)

ā€ƒOthers

3 (4.23%)

46 (22.77%)

  1. MPC multiple primary cancers, SPC single primary cancer, Others oropharynx, floor of mouth, jawbone, retromolar